Deciphering the potential molecular mechanism of resmetirom in idiosyncratic drug- induced autoimmune hepatitis using network toxicology and molecular docking
Key Points
Resmetirom affects molecular mechanisms crucial for autoimmune hepatitis treatment, promoting understanding of its therapeutic potential.
Key evidence shows resmetirom's interaction with specific molecular targets, enhancing its role in autoimmune hepatitis management.
Analysis utilizing network toxicology combined with molecular docking provides insights into drug interactions at the molecular level.
This work highlights the need for further exploration in clinical settings to confirm these findings and evaluate drug safety.
Décoder le mécanisme moléculaire potentiel du resmetirom dans l'hépatite auto-immune induite par des médicaments idiosyncratiques à l'aide de la toxicologie de réseau et du docking moléculaire. | Synapse